These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9561241)

  • 21. Development and testing of inhibitors of Candida aspartic proteinases.
    Pichová I; Brozková K; Pavlícková L; Fusek M; Krízová I; Ruml T; Soucek M
    Adv Exp Med Biol; 1998; 436():329-33. PubMed ID: 9561237
    [No Abstract]   [Full Text] [Related]  

  • 22. Extracellular aspartic proteinases from Candida yeasts.
    Fusek M; Smith E; Foundling SI
    Adv Exp Med Biol; 1995; 362():489-500. PubMed ID: 8540363
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
    Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
    FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and characterization of aspartic proteinase from sunflower seeds.
    Park H; Yamanaka N; Mikkonen A; Kusakabe I; Kobayashi H
    Biosci Biotechnol Biochem; 2000 May; 64(5):931-9. PubMed ID: 10879461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical coupling analysis of aspartic proteinases based on crystal structures of the Trichoderma reesei enzyme and its complex with pepstatin A.
    Nascimento AS; Krauchenco S; Golubev AM; Gustchina A; Wlodawer A; Polikarpov I
    J Mol Biol; 2008 Oct; 382(3):763-78. PubMed ID: 18675276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An artificial aspartic proteinase system.
    Jiang L; Liu Z; Liang Z; Gao Y
    Bioorg Med Chem; 2005 Jun; 13(11):3673-80. PubMed ID: 15862996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and properties of three intracellular proteinases from Candida albicans.
    Portillo F; Gancedo C
    Biochim Biophys Acta; 1986 Apr; 881(2):229-35. PubMed ID: 3513844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.
    Rich DH
    J Med Chem; 1985 Mar; 28(3):263-73. PubMed ID: 3882966
    [No Abstract]   [Full Text] [Related]  

  • 29. Aspartic proteinases in the digestive tract of marine decapod crustaceans.
    Navarrete del Toro Mde L; García-Carreño F; López MD; Celis-Guerrero L; Saborowski R
    J Exp Zool A Comp Exp Biol; 2006 Aug; 305(8):645-54. PubMed ID: 16788916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation.
    Yoshida H; Okamoto K; Iwamoto T; Sakai E; Kanaoka K; Hu JP; Shibata M; Hotokezaka H; Nishishita K; Mizuno A; Kato Y
    J Biochem; 2006 Mar; 139(3):583-90. PubMed ID: 16567424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding HTLV-I protease.
    Shuker SB; Mariani VL; Herger BE; Dennison KJ
    Chem Biol; 2003 May; 10(5):373-80. PubMed ID: 12770819
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification and characterization of an extracellular aspartate protease from Phycomyces blakesleeanus.
    De Vicente JI; De Arriaga D; Del Valle P; Soler J; Eslava AP
    Fungal Genet Biol; 1996 Jun; 20(2):115-24. PubMed ID: 8810516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the proteolytic activity firmly attached to yeast phoshoenolpyruvate carboxykinase.
    Beck I; Müller M; Holzer H
    Biochim Biophys Acta; 1982 Jul; 705(2):163-6. PubMed ID: 7052135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and preliminary characterization of poly(ethylene glycol)-pepstatin conjugate.
    Brygier J; Vincentelli J; Nijs M; Guermant C; Paul C; Baeyens-Volant D; Looze Y
    Appl Biochem Biotechnol; 1994 Apr; 47(1):1-10. PubMed ID: 8203868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymic and structural characterization of nepenthesin, a unique member of a novel subfamily of aspartic proteinases.
    Athauda SB; Matsumoto K; Rajapakshe S; Kuribayashi M; Kojima M; Kubomura-Yoshida N; Iwamatsu A; Shibata C; Inoue H; Takahashi K
    Biochem J; 2004 Jul; 381(Pt 1):295-306. PubMed ID: 15035659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of amino acid residues of the retroviral aspartic proteinases important for substrate specificity and catalytic efficiency.
    Cameron CE; Burstein H; Bizub-Bender D; Ridky T; Weber IT; Wlodawer A; Skalka AM; Leis J
    Adv Exp Med Biol; 1995; 362():399-406. PubMed ID: 8540349
    [No Abstract]   [Full Text] [Related]  

  • 37. Accumulation of pepstatin in cultured endothelial cells and its effect on endothelial processing.
    Shields PP; Gonzales TA; Charles D; Gilligan JP; Stern W
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1006-12. PubMed ID: 2059194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical characterization of an aspartic protease from Vigna radiata: Kinetic interactions with the classical inhibitor pepstatin implicating a tight binding mechanism.
    Kulkarni A; Rao M
    Biochim Biophys Acta; 2007 May; 1774(5):619-27. PubMed ID: 17478131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissection of the pH dependence of inhibitor binding energetics for an aspartic protease: direct measurement of the protonation states of the catalytic aspartic acid residues.
    Xie D; Gulnik S; Collins L; Gustchina E; Suvorov L; Erickson JW
    Biochemistry; 1997 Dec; 36(51):16166-72. PubMed ID: 9405050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor.
    Katoh I; Yasunaga T; Ikawa Y; Yoshinaka Y
    Nature; 1987 Oct 15-21; 329(6140):654-6. PubMed ID: 2821409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.